Braingenesis Biotechnology Co.,LTD - Developing innovative stroke treatment therapies

BrainGenesis Biotechnology Co. Ltd. was founded in December 1997, and is the heir of five thousand years of Chinese medicine and pharmacology.

Phase III human clinical trials of our new cardiovascular drug BNG-1 were completed at seven medical center hospitals in Taiwan during 2006. BNG-1 is now undergoing review by the Taiwan's Department of Health (DOH) Committee on Chinese Medicine and Pharmacy.

We expect that clinical trials will verify that the herbal medicine preparation BNG-1 can prevent and treat strokes. More...

Current chemical drugs are dogged by limited efficacy and such problems as side effects and drug resistance. Because the scientific method and modern pharmacological technology has verified that traditional Chinese herbal medicines yield significant efficacy against disease, the medical establishment is gradually gaining respect for the development and use of herbal medicines.

The herbal preparation BNG-1, a drug candidate developed by BrainGenesis, is based on four traditional Chinese medical materials together with four other secondary materials. More...

[Coming soon]